By: Forbes Real Time
March 08, 2013 at 10:43 AM EST
Merck's Big Vytorin Study Could Pose A Challenge For Amgen, Sanofi, And Regeneron, Too
Sometime this month, a group of independent experts will look at the data for the key study testing Merck's blockbuster cholesterol pills, Zetia and Vytorin. They could decide that the active ingredient in both is effective – or that it is unsafe.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here